Drugs / Trimethoprim/sulfamethoxazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01723150 | Nov 2013 → Jan 2018 | liver abscess (disease) | National University Hospital, Singapore | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01723150 ↗ |
| Route | Oral | “The intervention arm switched to oral antibiotics to complete 4 weeks of therapy. Oral antibiotics will be ciprofloxacin (or trimethoprim/sulfamethoxazole if the isolate is resistant).” NCT01723150 ↗ |